Response to JQ1 in various glioblastoma samples
ID | IC50, nmol/L | Emax, % | Subtype (32) | EGFR (38) | p53 (38) | Rb (35) | PTEN (38) |
---|---|---|---|---|---|---|---|
GBM6 | 150 | 90 | Classic | vIII | R273C | Gain | |
GBM8 | 400 | 47 | Classic | HD | |||
GBM10 | 200 | 25 | Mesenchymal | Loss | |||
GBM12 | 120 | 95 | Classic | 5,3 Osplice | |||
GBM16 | 300 | 29 | Mesenchymal | R273C | Loss | HD | |
GBM22 | 300 | 44 | Mesenchymal | Loss | |||
GBM39 | 200 | 52 | Mesenchymal | vIII | |||
GBM43 | 2000 | 86 | Mesenchymal | F270C | |||
GBM46 | 500 | 40 | Proneural | vIII | Loss | ||
T4105 | 300 | 83 | ND | ND | ND | ND | ND |
T4302 | 160 | 85 | ND | ND | ND | ND | ND |
T4597 | 60 | 88 | ND | ND | ND | ND | ND |
VU10369 | 500 | 59 | ND | ND | ND | ND | ND |
VU10827 | 130 | 65 | ND | ND | ND | ND | ND |
VU11014 | 700 | 60 | ND | ND | ND | ND | ND |
NOTE: Glioblastoma samples with a “GBM” prefix were short-term neurosphere cultures derived from primary glioblastoma xenograft lines serially passaged in mice. Samples with a “T” prefix were prospectively enriched CD133+ glioblastoma stem cells. Samples with a “VU” prefix were primary cultures directly isolated from patient surgical specimens (passage 3–7). IC50 values were determined after 5-day JQ1 treatment. The maximal effects (Emax) represented the inhibition rates of JQ1 at 5 μmol/L. Data represent the mean of 3 independent experiments.
Abbreviations: vIII, EGFR variant III; HD, homozygous deletion; ND, not determined.